China Isotope & Radiation Corp
HKEX:1763
China Isotope & Radiation Corp
Revenue
China Isotope & Radiation Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
China Isotope & Radiation Corp
HKEX:1763
|
Revenue
¥6.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Revenue
¥13.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Revenue
¥4.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Revenue
¥4.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Revenue
¥11.4B
|
CAGR 3-Years
35%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Revenue
¥3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
See Also
What is China Isotope & Radiation Corp's Revenue?
Revenue
6.1B
CNY
Based on the financial report for Dec 31, 2022, China Isotope & Radiation Corp's Revenue amounts to 6.1B CNY.
What is China Isotope & Radiation Corp's Revenue growth rate?
Revenue CAGR 5Y
18%
Over the last year, the Revenue growth was 19%. The average annual Revenue growth rates for China Isotope & Radiation Corp have been 16% over the past three years , 18% over the past five years .